XenoTherapeutics Corp — Form D
XenoTherapeutics Corp of Enfield, NH, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-21. The offering totals $4.0M. Industry: Biotechnology.
Offering
- Filed: 2019-05-21
- Form: D
- Accession: 0001774010-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Remaining: $4.0M
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-340069
Issuer
- Name: XenoTherapeutics Corp
- CIK: 0001774010
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3 Sunset Walk, Enfield, NH, 03748
- Phone: 2072630226
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Krysta Moulton | Director | Arlington, VA |
| Krysta Moulton | Executive Officer | Arlington, VA |
| Paul Holzer | Director | Enfield, NH |
| Paul Holzer | Executive Officer | Enfield, NH |
| Jon Adkins | Director | Londonderry, NH |
| Jon Adkins | Executive Officer | Londonderry, NH |
Other filings by this issuer (2)
More